Article

The Serum Galactomannan Index Predicts Mortality in Hematopoietic Stem Cell Transplant Recipients With Invasive Aspergillosis

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Clinical Infectious Diseases (Impact Factor: 9.42). 06/2013; 57(7). DOI: 10.1093/cid/cit393
Source: PubMed

ABSTRACT We examined the relationship between serum and BAL galactomannan index (GMI) values and mortality in allogeneic hematopoietic cell transplant recipients with invasive pulmonary aspergillosis (IPA). Using a clinical sign and symptom-initiated approach, we found that the serum but not the BAL GMI level correlated with 42- and 180-day patient mortality.

0 Followers
 · 
163 Views

Full-text

Download
80 Downloads
Available from
May 27, 2014